Artificial Intelligence

Quantitative Angiographic Systems


Ciprian N Ionita, PhD (Chief Executive Officer): Ciprian has more than 20 years of experience across the medical imaging, healthcare, software and technology industries. He is an assistant professor in The University at Buffalo’s Departments of Biomedical Engineering and Neurosurgery. Over the past 5 years, his research has led to the development of QAS.AI’s core technology. He is the director of the Endovascular Devices and Imaging lab at the Canon Stroke and Vascular Research Center focusing on the development of image-based tools to improve diagnosis and treatment outcomes in patients affected by various vascular diseases. He holds a PhD in Medical Physics from the University at Buffalo.

QAS.AI Inc., is a C-corporation focused on the development and commercialization of software integrated with image guided surgical equipment to optimize neurovascular treatments.  Our multidisciplinary team has expertise in biomedical engineering, neurosurgery and pathology. 

Clinical Advisory Board

Jason Davies, MD, PhD – (Chief Medical Officer): Dr. Davies received his MD and PhD in Biophysics from Stanford. Dr. Jason Davies is an Assistant Professor of Neurosurgery and Biomedical Informatics at the State University of New York (SUNY) at Buffalo. Dr. Davies performs endovascular and surgical interventions on IAs at the Gates Vascular Institute (GVI) and has experience with national clinical trials, as well as cutting-edge research at the university. His active research interests focus on using bioinformatics tools to advance personalized medicine. He is working to develop bioinformatics tools to improve the quantity and quality of data available for medical research, and to lower barriers to entry for all clinicians to contribute to medical knowledge. Furthermore, he is working to bring to bear more advanced machine learning and data analytic methods to better understand the insights contained within these rich data resources.

Vincent M Tutino, PhD – (Chief Financial Officer): Dr. Tutino received his Masters and PhD in Biomedical Engineering from The University at Buffalo. He has been extensively trained in translational research and has a strong background in diagnostics development and computational methods in medical research. He is also an entrepreneur and has spun-off other startup companies in Buffalo, NY. As President and CEO of Neurovascular Diagnostics, Inc. he has successfully received and managed several Phase I and Phase II SBIR grants from the NSF and NIH.

Elad I Levy, MD, MBA – Dr. Elad Levy is Professor of Neurosurgery and Radiology, L. Nelson Hopkins, MD Chairman of the Department of Neurological Surgery, Jacobs School of Medicine at Biomedical Sciences, at State University of New York at Buffalo.  Dr. Levy is also the Co-Director, Gates Stroke Center and Cerebrovascular Surgery at Kaleida Health, Director of Endovascular Stroke Treatment and Research Medical Director of Neuroendovascular Services at Gates Vascular Institute (GVI). Dr. Levy has a national and global reputation in the field of neurovascular disease, and has co-authored over 300 peer-reviewed publications, including several in the New England Journal of Medicine. Prior to his professorship at the University, Dr. Levy graduated from Dartmouth College and received his Doctor of Medicine degree with distinction from George Washington University

Adnan H Siddiqui, MD, PhD -  Dr. Adnan Siddiqui is a Professor of Neurosurgery and Radiology who joined University at Buffalo Neurosurgery in January 2007. He completed fellowship training in Interventional Neuroradiology, Cerebrovascular Surgery and Neurocritical Care from Thomas Jefferson University in Philadelphia. He completed his Neurosurgical residency at Upstate Medical University and received his PhD in Neuroscience from the University of Rochester and medical degree from Aga Khan University, Pakistan. Though Dr. Siddiqui is well trained in all general neurosurgical procedures, including brain tumor, spine and peripheral nerve surgery, because of specialized training, he has gravitated toward vascular diseases involving the brain and spinal cord. The Neuroendovascular Research and Stroke Service is led by Dr. Siddiqui, who is proud to play a leadership role in UB’s Department of Neurosurgery, which was ranked 7th in academic impact in North America by the Journal of Neurosurgery.

Kenneth V Snyder, MD, PhD – Dr. Snyder joined University at Buffalo Neurosurgery in 2011 after completing his fellowship training in endovascular neurosurgery with UB Neurosurgery and spent 6 months as a research fellow at the Barrow Neurological Institute. He completed his neurosurgical residency at UB and received his PhD in biophysics specializing in mechanoelectric transduction of cellular membranes. He is trained in all general neurosurgical procedures, including brain tumor, spine, and peripheral nerve surgery.

Maxim Mokin, MD PhD – Dr Mokin is Associate Professor at the University of South Florida and its affiliated clinical site Tampa General Hospital. His clinical practice is focused on cerebrovascular disease, including the medical and endovascular treatment of patients with acute ischemic stroke, and endovascular treatment of brain aneurysms and vascular malformations. He also holds a Ph.D. in Neurosciences where he investigated the use of in vitro models of learning and memory. He participates in numerous research projects involving clinical interventionalists of different backgrounds, stroke physicians, basic scientists and engineers. 


Mohammad Mahdi Shiraz Bhurwani, PhD – (Chief Technology Officer and Senior AI Scientist): Dr. Bhurwani received his Masters and PhD in Biomedical Engineering from the University at Buffalo. He has a strong background in the development of machine learning and artificial intelligence algorithms with medical imaging modalities. His doctoral research at the Canon Stroke and Vascular Research Center in Buffalo has been the foundational research upon which QAS.AI has been built.